Total Funding
84
23
Total FundingSeed raised
Growth Score
-5 pts
Heat Score
11 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
363426
Medafor develops novel hemostatic technology and absorbable hemostats called MPH(R), which accelerates the normal blood clotting process.
Jon Freeman: Chief Financial Officer
About the Company
Medafor, Inc. is a medical device company that has developed and commercialized a patented hemostatic agent that has been shown to enhance and accelerate the normal blood clotting process. Medafor’s MPH technology is unparalleled in terms of safety, efficacy, and cost.
